Financial Network Wealth Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Financial Network Wealth Advisors’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.19K	Buy	74 +18	+32%	+$298	﹤0.01%	776
2026 Q1	$1.04K	Buy	+56	New	+$983	﹤0.01%	737

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Financial Network Wealth Advisors's TAK Position: Q2 2026 in Review

Financial Network Wealth Advisors increased its Takeda Pharmaceutical (TAK) stake by 32% in Q2 2026, buying an estimated $298 and bringing the position to 74 shares worth $1.19K. The position accounts for ﹤0.01% of the portfolio, ranked #776.

Financial Network Wealth Advisors first reported a position in TAK in Q1 2026 and has held it in 2 quarters since. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Financial Network Wealth Advisors held 74 shares of Takeda Pharmaceutical worth $1.19K as of Q2 2026.
Financial Network Wealth Advisors bought 18 Takeda Pharmaceutical shares in Q2 2026, an estimated $298.
Takeda Pharmaceutical made up ﹤0.01% of Financial Network Wealth Advisors's portfolio in Q2 2026, its #776 holding.
Financial Network Wealth Advisors first reported a position in Takeda Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Financial Network Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.